Digest Network Come funziona
Network
/
Società
Sc
Non verificato

Scholar Rock

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieMercato azionarioSalute

83 comunicati stampa

Guarda tutti i comunicati
11/09/2026
Telefonia e Varie
Industria
Scienza
Farmaceutica
Vetrine/Shopping
Infanzia
Medicina - Varie
Biotecnologia
Igiene alimentare
Salute
Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
02/09/2026
Industria
Sanità
Scienza
Farmaceutica
Biotecnologia
Medicina - Varie
Attrezzature medico-sanitarie
Igiene alimentare
Salute
Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (FSHD) Program as Participant Dosing Commences in Phase 2 FORGE Trial
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
27/08/2026
Eventi
Web e Social Network
Biotecnologia
Sanità
Salute
Farmaceutica
Scholar Rock to Present at Upcoming Investor Conferences
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
21/08/2026
Industria
Attrezzature medico-sanitarie
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
07/08/2026
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
06/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Attrezzature medico-sanitarie
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Scholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
29/07/2026
Web e Social Network
Eventi
Attrezzature medico-sanitarie
Salute
Igiene alimentare
Biotecnologia
Farmaceutica
Scholar Rock to Present at the Canaccord Genuity 46th Annual Growth Conference
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
20/07/2026
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (CHMP) Opinion for Apitegromab Marketing Authorisation Application (MAA) for Spinal Muscular Atrophy (SMA)
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
17/07/2026
Biotecnologia
Farmaceutica
Salute
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0
16/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026
Fonte
Scholar Rock
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0